should glp-1 agonists be open access You might know them as Ozempic, Wegovy, Mounjaro, and Zepbound. receptor are best known for managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective GLP-1 Drug Savings: A Complete

Correlation Between GLP-1 and Non-Alcoholic Steatohepatitis There is currently a significant increase in the rate of patients with non-alcoholic fatty liver disease (NAFLD) with its prevalence rate reaching up to 40%

Our Sequoia pharmacy advisory team is here to help you navigate the evolving market. If youre interesting in exploring how Sequoia can help design a plan that manages pharmaceutical and healthcare costs, reach out to a Sequoia advisor.

Talk to your doctor before taking GLP-1 medications if you have any of the following conditions: A personal or family history of medullary thyroid cancer or acute pancreatitis Type 1 diabetes mellitus Pregnant, planning to become pregnant in the next 3 months, or nursing Delivered a baby within the past 6 months Ongoing heavy alcohol use Active eating disorder, anorexia, or purging

Liver Fibrosis Percentage based on PSR Staining

The shift to weekly formulations began with Bydureon in 2012 and became standard by 2017

Contrasting effects of GLP1-RAs and DPP-4Is across species GLP-1RAs and DPP-4Is both modulate the GLP-1 system but through distinct mechanisms